全球細菌性疾病診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計細菌性疾病診斷市場將從 2025 年的 42.5 億美元成長到 2034 年的 85.8 億美元，2026 年至 2034 年的複合年成長率為 8.12%。

全球細菌性疾病診斷市場正穩步成長，這主要得益於細菌感染疾病負擔的加重以及對快速、準確診斷解決方案日益成長的需求。醫院和實驗室擴大採用先進的診斷工具，以快速識別致病菌並制定合適的治療方案。此外，人們對抗菌素抗藥性的日益關注也促使醫療專業人員採用更精準的診斷方法。

分子診斷、聚合酵素鏈鎖反應(PCR) 和自動化檢測系統的技術進步顯著提高了細菌性疾病檢測的效率和準確性。政府為促進早期診斷和加大醫學研究投入而採取的措施進一步推動了市場成長。此外，診斷檢查室的擴展和就地檢驗的日益普及也促進了細菌診斷需求的成長。

未來，快速診斷技術的創新以及人工智慧（AI）在診斷系統中的應用預計將對市場產生積極影響。隨著人們對個人化醫療和標靶治療的興趣日益成長，對精準細菌檢測方法的需求也將進一步增加。此外，新興經濟體醫療基礎設施的持續發展預計將帶來新的成長機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球細菌性疾病診斷市場：依產品類型分類

• 市場分析、洞察與預測
• 診斷試劑盒
• 裝置
• 試劑和耗材

第5章 全球細菌性疾病診斷市場：依檢測類型分類

• 市場分析、洞察與預測
• 培養試驗
• 顯微鏡檢查
• 生化試驗
• 分子檢測
• 血清學檢測

第6章 全球細菌性疾病診斷市場：依技術分類

• 市場分析、洞察與預測
• 聚合酵素鏈鎖反應（PCR）
• 酵素免疫分析法（ELISA）
• 次世代定序（NGS）
• 基質輔助雷射解吸飛行時間（MALDI-TOF）質譜
• 微陣列技術
• 文化技術
• 其他（例如，奈米定序）

第7章 全球細菌性疾病診斷市場：依樣本類型分類

• 市場分析、洞察與預測
• 血
• 尿
• 痰
• 航班
• 腦脊髓液（CSF）
• 其他（例如，組織樣本）

第8章 全球細菌性疾病診斷市場：依應用領域分類

• 市場分析、洞察與預測
• 呼吸道感染疾病
• 胃腸道感染疾病
• 尿道感染（UTI）
• 性行為感染感染（STI）
• 院內感染（HAI）
• 其他（皮膚感染疾病等）

第9章 全球細菌性疾病診斷市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院及門診手術中心
• 診斷檢查室
• 學術研究機構
• 其他（診所等）

第10章 全球細菌性疾病診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第11章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第12章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • Siemens Healthineers
  • Becton Dickinson And Company
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Danaher Corporation
  • QIAGEN NV
  • Bio-Rad Laboratories Inc
  • Revvity
  • DiaSorin SpA
  • Thermo Fisher Scientific Inc

The Bacterial Disease Diagnostics Market size is expected to reach USD 8.58 Billion in 2034 from USD 4.25 Billion (2025) growing at a CAGR of 8.12% during 2026-2034.

The global bacterial disease diagnostics market is growing steadily due to the increasing burden of bacterial infections and the rising demand for rapid and accurate diagnostic solutions. Hospitals and laboratories are increasingly adopting advanced diagnostic tools to identify bacterial pathogens quickly and guide appropriate treatment. The growing awareness about antimicrobial resistance is also encouraging healthcare providers to adopt precise diagnostic methods.

Technological advancements such as molecular diagnostics, polymerase chain reaction (PCR), and automated testing systems are significantly improving the efficiency and accuracy of bacterial disease detection. Government initiatives promoting early disease diagnosis and investments in healthcare research are further supporting market growth. Additionally, the expansion of diagnostic laboratories and the increasing adoption of point-of-care testing are contributing to the rising demand for bacterial diagnostics.

In the future, the market is expected to benefit from innovations in rapid diagnostic technologies and the integration of artificial intelligence in diagnostic systems. The increasing focus on personalized medicine and targeted treatment approaches will further strengthen demand for accurate bacterial detection methods. Emerging economies are also expected to create new growth opportunities as healthcare infrastructure continues to expand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Diagnostic Kits
• Instruments
• Reagents And Consumables

By Test Type

• Culture-Based Tests
• Microscopy
• Biochemical Tests
• Molecular Tests
• Serological Tests

By Technology

• Polymerase Chain Reaction (PCR)
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Next-Generation Sequencing (NGS)
• Matrix-Assisted Laser Desorption Time of Flight (MALDI-TOF) Mass Spectrometry
• Microarray Technology
• Culturing Techniques
• Others (Nanopore Sequencing, etc.)

By Sample Type

• Blood
• Urine
• Sputum
• Stool
• Cerebrospinal Fluid (CSF)
• Others (Tissue Sample, etc.)

By Application

• Respiratory Infections
• Gastrointestinal Infections
• Urinary Tract Infections (UTIs)
• Sexually Transmitted Infections (STIs)
• Hospital-acquired Infections (HAIs)
• Others (Skin Infections, etc.)

By End-user

• Hospitals & Ambulatory Surgical Centers
• Diagnostic Laboratories
• Academic & Research Institutes
• Others (Clinics, etc.)

COMPANIES PROFILED

• Abbott, Siemens Healthineers, Becton Dickinson and Company, Quest Diagnostics, QuidelOrtho Corporation, Sysmex Corporation, Danaher Corporation, QIAGEN NV, BioRad Laboratories Inc, Revvity, DiaSorin SpA, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Diagnostic Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Reagents And Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Test Type
• 5.2. Culture-Based Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Microscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biochemical Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Molecular Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Serological Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Polymerase Chain Reaction (PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Next-Generation Sequencing (NGS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Matrix-Assisted Laser Desorption Time of Flight (MALDI-TOF) Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Microarray Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Culturing Techniques Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others (Nanopore Sequencing, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Sample Type
• 7.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Sputum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Stool Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Cerebrospinal Fluid (CSF) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others (Tissue Sample, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Respiratory Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Gastrointestinal Infections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Urinary Tract Infections (UTIs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Sexually Transmitted Infections (STIs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Hospital-acquired Infections (HAIs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Others (Skin Infections, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast End-user
• 9.2. Hospitals & Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Others (Clinics, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL BACTERIAL DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product Type
  • 10.2.2 By Test Type
  • 10.2.3 By Technology
  • 10.2.4 By Sample Type
  • 10.2.5 By Application
  • 10.2.6 By End-user
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product Type
  • 10.3.2 By Test Type
  • 10.3.3 By Technology
  • 10.3.4 By Sample Type
  • 10.3.5 By Application
  • 10.3.6 By End-user
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product Type
  • 10.4.2 By Test Type
  • 10.4.3 By Technology
  • 10.4.4 By Sample Type
  • 10.4.5 By Application
  • 10.4.6 By End-user
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product Type
  • 10.5.2 By Test Type
  • 10.5.3 By Technology
  • 10.5.4 By Sample Type
  • 10.5.5 By Application
  • 10.5.6 By End-user
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product Type
  • 10.6.2 By Test Type
  • 10.6.3 By Technology
  • 10.6.4 By Sample Type
  • 10.6.5 By Application
  • 10.6.6 By End-user
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL BACTERIAL DISEASE DIAGNOSTICS INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Abbott
  • 12.2.2 Siemens Healthineers
  • 12.2.3 Becton Dickinson And Company
  • 12.2.4 Quest Diagnostics
  • 12.2.5 QuidelOrtho Corporation
  • 12.2.6 Sysmex Corporation
  • 12.2.7 Danaher Corporation
  • 12.2.8 QIAGEN N.V
  • 12.2.9 Bio-Rad Laboratories Inc
  • 12.2.10 Revvity
  • 12.2.11 DiaSorin S.p.A
  • 12.2.12 Thermo Fisher Scientific Inc